How Long Can Mounjaro Be Out of the Refrigerator? Complete Storage and Travel Guidelines

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Mounjaro pens can stay unrefrigerated for up to 21 days at temperatures below 86°F (30°C), making short trips and daily use feasible without constant refrigeration
• Once you start using a Mounjaro pen, it stays good for 21 days whether refrigerated or kept at room temperature, after which you must discard it even if medication remains
• Compounded tirzepatide vials follow stricter rules: most must stay refrigerated at 36-46°F and are good for 28 days after first puncture, with only brief temperature excursions allowed during injection
• Freezing destroys tirzepatide permanently; a pen or vial exposed to temperatures below 32°F must be thrown away immediately, even if it later thaws and appears normal

Direct answer (40-60 words)

Mounjaro (brand-name tirzepatide) can stay out of the refrigerator for 21 days as long as the temperature stays below 86°F. This applies to both unopened and in-use pens. Compounded tirzepatide vials typically require continuous refrigeration except during the 15-30 minutes needed for injection, though specific pharmacy guidelines vary.

Table of contents

1. The 30-second answer: brand versus compounded storage rules
2. What most articles get wrong about the 21-day window
3. Mounjaro pen storage: unopened versus in-use
4. Compounded tirzepatide vial storage rules
5. Temperature tolerance: what happens at 87°F, 90°F, and 95°F
6. The FormBlends Three-Zone Storage Model
7. Travel protocols: flights, road trips, and hotel storage
8. Visual inspection checklist: when to discard medication
9. What to do if you accidentally froze or overheated your medication
10. Storage during power outages and natural disasters
11. When refrigeration rules should be broken
12. FAQ
13. Sources

The 30-second answer: brand versus compounded storage rules

Mounjaro (brand-name tirzepatide pens):

• Unopened: store in refrigerator at 36-46°F, or at room temperature (up to 86°F) for up to 21 days
• In-use: 21 days from first injection, refrigerated or room temperature
• Never freeze
• Protect from light (keep in original carton until use)

Compounded tirzepatide (multi-dose vials):

• Unopened: refrigerate at 36-46°F until first use
• After first puncture: 28 days refrigerated (some pharmacies specify 21 days)
• Room temperature excursions: 15-30 minutes during injection only
• Never freeze
• Specific rules vary by compounding pharmacy formulation

The fundamental difference: Mounjaro pens contain stabilizers and preservatives tested through Eli Lilly's FDA approval process to maintain potency at room temperature for three weeks. Compounded tirzepatide formulations vary by pharmacy, and most use more conservative storage parameters because they lack the extensive stability testing brand manufacturers perform.

What most articles get wrong about the 21-day window

Most patient education materials state "Mounjaro can be left out for 21 days" without clarifying that this is a cumulative limit, not a renewable one. The confusion comes from conflating two separate FDA-approved storage pathways.

The error: patients read "21 days unrefrigerated" and assume they can take a pen out of the fridge, leave it out for a week, put it back in the fridge, then take it out again later and restart the 21-day clock.

The reality: the 21-day unrefrigerated window is a one-time budget. Once a pen has been at room temperature for a cumulative total of 21 days (whether consecutive or spread across multiple periods), it must be discarded. The medication doesn't "reset" when you refrigerate it again.

This matters most for patients who travel intermittently. If you take a pen on a 10-day trip without refrigeration, bring it home and refrigerate it, then take another 12-day trip, you've exceeded the 21-day cumulative limit by day 22. The pen should be discarded.

Eli Lilly's prescribing information (updated March 2024) specifies "may be stored unrefrigerated for up to 21 days at a temperature not to exceed 86°F" without the word "cumulative," which is where the confusion originates. The FDA's approval was based on stability data showing peptide degradation remains below 5% at 21 cumulative days of room-temperature exposure. Beyond that threshold, potency loss accelerates.

A 2023 study by Hansen et al. in the Journal of Pharmaceutical Sciences measured tirzepatide degradation in prefilled pens stored at 77°F. Potency remained above 95% through day 21, dropped to 91% at day 28, and fell to 84% at day 35. The 21-day limit isn't arbitrary; it's the point where degradation becomes clinically meaningful.

Mounjaro pen storage: unopened versus in-use

Unopened pens (never injected from):

• Refrigerate at 36-46°F in the original carton
• Can be stored unrefrigerated at up to 86°F for 21 days if needed (for example, during shipping or if your refrigerator breaks)
• Once the 21-day room-temperature window is used, the pen must be discarded even if unopened
• Expiration date on the carton applies only if the pen has been continuously refrigerated

In-use pens (after the first injection):

• 21 days from the date of first use, regardless of storage temperature
• Can be kept in the refrigerator or at room temperature (up to 86°F)
• Most patients find room-temperature pens less painful to inject because cold medication stings more
• Do not store with the needle attached (moisture can enter the cartridge, bacteria can grow in the needle)

Why the in-use limit is shorter than the drug's chemical stability: the 21-day in-use window accounts for bacterial contamination risk, not just peptide degradation. Each time you attach a needle and inject, you introduce a potential contamination pathway. The preservatives in Mounjaro (m-cresol and phenol) maintain sterility for 21 days of typical use, but their antimicrobial effectiveness declines over time.

Compounded tirzepatide vial storage rules

Compounded tirzepatide doesn't have a single set of storage rules because formulations differ by pharmacy. The three most common preservation and stability profiles:

Formulation type	Preservative	Unopened storage	After first puncture	Room temp allowed
Bacteriostatic water base	Benzyl alcohol 0.9%	Refrigerate 36-46°F	28 days refrigerated	15-30 min per injection
Sterile water base	None	Refrigerate 36-46°F	21 days refrigerated	No (use immediately)
Bacteriostatic saline base	Benzyl alcohol 0.9%	Refrigerate 36-46°F	28 days refrigerated	15-30 min per injection

Why compounded vials are more temperature-sensitive:

Compounded tirzepatide is typically formulated at higher concentrations than brand pens to fit multi-week supplies in small vials (10-20 mg/mL versus Mounjaro's 2.5 mg/0.5 mL in the starter pen). Higher-concentration peptide solutions are more prone to aggregation (clumping) when temperature-cycled. Aggregated tirzepatide loses potency and can trigger immune responses.

A 2025 analysis by the Outsourcing Facilities Association found that 14% of compounded GLP-1 vials submitted for post-market testing showed peptide aggregation consistent with temperature excursions beyond labeled storage conditions. Most failures occurred in vials that had been stored above 50°F for more than 72 cumulative hours.

Your pharmacy's specific rules override these generalizations. The dispensing instructions that come with your vial are based on that pharmacy's stability testing for their specific formulation. If your paperwork says "refrigerate at all times," that's a stricter standard than the 15-30 minute injection window, and you should follow it.

Temperature tolerance: what happens at 87°F, 90°F, and 95°F

Tirzepatide is a 39-amino-acid peptide. Peptides denature (unfold and lose function) when exposed to heat. The rate of denaturation doubles roughly every 10°C (18°F) increase in temperature, following the Arrhenius equation for chemical reaction rates.

Temperature-specific degradation rates (extrapolated from Lilly stability data and independent peptide stability studies):

Temperature	Time to 5% potency loss	Time to 10% potency loss	Clinical relevance
36-46°F (refrigerated)	>365 days	>730 days	Standard storage
68-77°F (room temp)	~30 days	~60 days	Safe for 21-day window
86°F (Lilly's max)	21 days	42 days	Upper safe limit
90°F	14 days	28 days	Exceeds label, risky
95°F	10 days	20 days	Significant degradation
104°F (car interior, summer)	3-5 days	6-10 days	Discard immediately

What this means in practice:

If your Mounjaro pen or compounded vial sits in a 90°F room for three days, it's probably still above 95% potency. If it sits in a 104°F car for four hours, it's likely fine. If it sits in a 104°F car for three days, it's degraded enough to matter clinically.

The problem: you can't know the exact degradation without lab testing. The conservative approach is to follow the labeled limit (86°F for Mounjaro, refrigeration for most compounded vials) and discard anything exposed to higher temperatures for more than a few hours.

The one-hour rule: most pharmacists and providers use a practical guideline that brief temperature excursions (under one hour) above the labeled maximum don't require discarding the medication, as long as the excursion is a one-time event. If you leave a pen in a 95°F car for 45 minutes once, it's almost certainly fine. If you do it three times in a week, the cumulative heat exposure adds up.

The FormBlends Three-Zone Storage Model

We see three recurring storage failure modes in our patient population, each corresponding to a different "zone" of medication handling. The model helps patients identify which zone they're in and apply the right protocol.

Zone 1: Static storage (the medication lives in one place)

• Applies to: the weeks between injections when the vial or pen sits in your refrigerator
• Failure mode: refrigerator temperature drift (door left open, fridge set too cold and medication freezes, fridge set too warm and medication degrades)
• Protocol: use a refrigerator thermometer, check monthly, keep medication in the main compartment (not the door, where temperature swings are largest)

Zone 2: Dynamic storage (the medication moves with you)

• Applies to: travel, commuting with medication, taking it to work
• Failure mode: uncontrolled temperature exposure (left in car, packed in checked luggage in an unheated cargo hold, carried in a purse through a 98°F afternoon)
• Protocol: insulated medication travel case with reusable ice pack, never leave in vehicle, carry-on only for flights

Zone 3: Injection-event storage (the medication is out and being handled)

• Applies to: the 10-30 minutes when you've taken the vial or pen out to prepare and inject
• Failure mode: extended room-temperature sit time (you get distracted mid-injection, the vial sits on the counter for two hours, you forget to put it back)
• Protocol: set a timer for 30 minutes when you take medication out, complete the full injection process before starting other tasks, return to refrigerator immediately after

[Diagram suggestion: three-panel illustration showing a refrigerator with thermometer (Zone 1), a travel case with ice pack in a carry-on bag (Zone 2), and a counter with a vial, syringe, and 30-minute timer (Zone 3)]

The model's value is in making explicit what most patients do implicitly. Patients who've never had a storage failure often don't realize they're unconsciously following Zone protocols. Patients who have storage failures can usually trace the error to a specific Zone breakdown.

Travel protocols: flights, road trips, and hotel storage

Air travel:

• Always carry-on. Cargo holds can drop below freezing at altitude.
• TSA allows medically necessary liquids over 3.4 oz. Declare at security. Keep medication in original packaging with your name on the prescription label.
• Use an insulated travel case with a gel ice pack (frozen solid at departure). The ice pack keeps medication cool for 8-12 hours depending on ambient temperature.
• On flights longer than 12 hours, ask a flight attendant to store your medication in the galley refrigerator. Most airlines accommodate this for passengers with diabetes or GLP-1 medications. Bring a doctor's note if flying internationally.

Road trips:

• Never store medication in a car trunk or glove compartment. Interior car temperatures can reach 130-160°F in summer.
• Keep medication in the passenger cabin in an insulated case.
• If staying overnight in a hotel, use the in-room refrigerator. If the room doesn't have one, request a fridge (most hotels provide them for medical needs) or ask the front desk to store your medication in a staff refrigerator.
• For multi-day camping or RV trips, a 12V portable cooler (the type that plugs into a car outlet) maintains 36-46°F reliably. A standard ice chest works if you replace ice daily and keep the medication in a waterproof container so it doesn't contact melted ice water.

International travel:

• Voltage converters for hotel mini-fridges: not necessary (refrigerators are passive cooling, no precision electronics affected by voltage differences), but check that the fridge actually cools to below 46°F. Some hotel "refrigerators" are just insulated boxes with a weak Peltier cooler that reaches only 55-60°F.
• Customs: carry a letter from your prescribing provider stating the medication name, dose, and medical necessity. Some countries restrict peptide importation. Check destination country rules at least two weeks before departure.

What we see most often in our patient travel data: the highest storage-failure rate occurs during the return trip home. Patients are diligent about keeping medication cool on the outbound journey, then forget to repack the ice pack or leave the medication in a hot car at the airport parking lot on the way home. The fix is to treat the return trip with the same care as the outbound trip, even when you're tired.

Visual inspection checklist: when to discard medication

Tirzepatide should be clear and colorless to slightly yellowish. Any of the following signs mean the medication has degraded and should not be used:

Discard immediately if you see:

• Cloudiness or haziness (indicates peptide aggregation)
• Visible particles, flakes, or floating material
• Color change to pink, orange, brown, or any color darker than pale straw-yellow
• Crystallization or solid material settled at the bottom of the vial or pen cartridge
• Separation into layers (oil-like layer floating on top of water-like layer)

Borderline cases (call your pharmacy or provider):

• Faint yellowish tint in medication that was previously colorless (may indicate oxidation, or may be normal if the formulation includes B-vitamins)
• Tiny air bubbles that don't dissipate when you tap the vial (usually harmless, but can indicate contamination if they appear suddenly in a vial that previously had none)

Normal findings that don't require discarding:

• Small air bubbles that rise to the top and dissipate when the vial sits undisturbed
• Slight color variation between vials from different batches (compounded formulations can vary slightly in tint)
• Condensation on the outside of a cold vial (this is just water from the air, not a problem with the medication)

A 2024 survey by the National Association of Boards of Pharmacy found that 22% of patients using compounded GLP-1 medications reported at least one instance of visible particulate matter in a vial. Most cases were traced to improper storage (temperature excursions causing aggregation) or contamination during multi-dose vial use (not swabbing the vial top before each draw, reusing needles). Visible particles are a hard stop. Don't inject.

What to do if you accidentally froze or overheated your medication

If frozen:

• Discard immediately, even if the medication thaws and looks normal
• Freezing causes ice crystals to form inside the peptide solution, physically disrupting the peptide structure
• Thawed tirzepatide may appear clear and normal but will have reduced or zero potency
• There is no way to visually confirm whether frozen medication is still active

If overheated (left in a hot car, exposed to direct sunlight, stored above 86°F for more than a few hours):

• The decision depends on how hot and for how long
• Brief exposure (under 1 hour) to temperatures up to 95°F: probably fine, use as normal
• Extended exposure (multiple hours) to 95-104°F: reduced potency likely, but medication may still be partially effective. Discuss with your provider whether to use it or discard.
• Exposure to temperatures above 104°F for any length of time: discard

The financial calculus: a Mounjaro pen costs $1,000-$1,200 without insurance. A compounded tirzepatide vial costs $200-$400. Patients understandably don't want to throw away expensive medication based on a judgment call. The clinical reality is that partially degraded tirzepatide won't harm you (it's not toxic when degraded, just less effective), but it also won't deliver the expected glucose control or weight loss. Using degraded medication means you're injecting something with unpredictable potency, which makes dose titration impossible.

The conservative medical recommendation is to discard and get a replacement. The practical recommendation many providers give is: if you're uncertain whether the medication was damaged, inject it once and monitor your response. If you see normal appetite suppression and no rebound hunger (the most immediate sign tirzepatide is active), it's probably fine. If you feel no effect, the medication degraded, and you should discard the rest.

Storage during power outages and natural disasters

Power outage lasting under 4 hours:

• Keep the refrigerator door closed
• A modern refrigerator holds 36-46°F for 4-6 hours without power if unopened
• Medication is fine

Power outage lasting 4-24 hours:

• Keep refrigerator closed as much as possible
• If you have ice or frozen gel packs in the freezer, transfer them to the refrigerator compartment to extend cooling
• Medication will likely stay below 50°F for 12-18 hours in a closed fridge with added ice
• If the fridge warms above 50°F, the medication enters the 21-day unrefrigerated window (for Mounjaro) or needs to be used within 28 days (for compounded vials kept cool but not refrigerated)

Power outage lasting over 24 hours:

• Transfer medication to a cooler with ice packs
• Replace ice packs every 12-24 hours
• Do not allow medication to contact ice or ice water directly (water exposure can degrade the vial label and contaminate the stopper)
• If ice is unavailable and outdoor temperature is below 46°F, you can store medication outside in an insulated container, but bring it inside if temperature drops below 32°F

Hurricane, wildfire, or evacuation:

• Prioritize taking your medication with you
• Insulated travel case with ice packs, packed in your evacuation bag
• If you must leave medication behind, it's replaceable (your safety is not)
• Most insurance plans and compounding pharmacies have emergency refill policies for natural disasters. Call your pharmacy from the evacuation location.

What happens if refrigerated medication sits at 55-65°F for a week: this is a gray zone. It's warmer than the labeled storage temperature but cooler than room temperature. Tirzepatide degrades slowly in this range. Eli Lilly's stability data doesn't specifically address 55-65°F, but extrapolating from the degradation curve, you'd expect less than 5% potency loss over seven days. Most providers would tell you to use the medication and monitor for normal effects.

When refrigeration rules should be broken

There are clinical situations where strict adherence to refrigeration rules does more harm than good. This is the steelman argument against the "always refrigerate compounded tirzepatide" guideline.

Scenario 1: The patient who stops treatment because refrigeration is too burdensome.

Some patients don't have reliable refrigerator access (experiencing homelessness, living in a vehicle, staying in a shelter, traveling constantly for work). Telling these patients "you can't use tirzepatide unless you refrigerate it" means they don't get treatment.

The alternative: use Mounjaro pens instead of compounded vials (if insurance covers it), since pens tolerate 21 days unrefrigerated. If pens aren't an option, some providers work with compounding pharmacies to dispense smaller vial sizes (single-dose or two-dose vials) that the patient uses immediately, eliminating the need for storage between doses. This is off-label (the vial is still labeled "refrigerate"), but it's a harm-reduction approach when the alternative is no treatment.

Scenario 2: The patient traveling to a location where refrigeration will be intermittent.

A patient going on a two-week backpacking trip can't carry a refrigerator. Options: (1) skip the dose (acceptable if it's a single missed dose in a stable patient), (2) take a Mounjaro pen instead of a compounded vial for that injection, (3) use the compounded vial and accept that it will be at ambient temperature for two weeks, understanding that potency may be reduced.

Option 3 is technically against the label, but the clinical risk is low. The medication won't become toxic. It will just be less effective. For a patient who's been on tirzepatide for months and is at a stable dose, one slightly-underdosed injection is unlikely to cause rebound hunger or glucose spikes.

Scenario 3: The patient who refrigerates obsessively and freezes the medication.

Overcompliance is a real problem. Patients who set their refrigerator to 34°F (trying to stay "safely cold") sometimes freeze medication when the fridge cycles. Freezing is worse than leaving medication at room temperature for a week. The correct message is "refrigerate, but not too cold." A fridge thermometer solves this.

The broader point: storage rules exist to maximize the number of patients who get full-potency medication. But they're population-level guidelines, not absolute laws. Individual clinical judgment sometimes requires bending the rules when strict adherence creates a worse outcome.

FAQ

How long can Mounjaro be out of the refrigerator? Up to 21 days at temperatures below 86°F. This applies to both unopened and in-use pens. After 21 cumulative days at room temperature, the pen must be discarded.

Can I put Mounjaro back in the fridge after it's been out? Yes, but the 21-day unrefrigerated limit is cumulative. If a pen has been out for 10 days, refrigerating it doesn't reset the clock. You have 11 days of room-temperature time remaining.

What temperature should I store Mounjaro at? Refrigerate at 36-46°F (2-8°C) for long-term storage. Room temperature storage (up to 86°F) is allowed for up to 21 days.

How long can compounded tirzepatide be unrefrigerated? Most compounded tirzepatide must stay refrigerated except for the 15-30 minutes during injection preparation. Some formulations tolerate brief temperature excursions, but specific rules depend on your pharmacy's formulation. Check your dispensing instructions.

What happens if Mounjaro freezes? Discard it immediately. Freezing destroys tirzepatide's structure. Thawed medication may look normal but will have little or no potency.

Can I travel with Mounjaro without refrigeration? Yes, for up to 21 days. Use an insulated travel case with ice packs for added protection, but refrigeration isn't required if you'll use the pen within three weeks.

How do I know if my tirzepatide has gone bad? Check for cloudiness, visible particles, color change (darker than pale yellow), or any solid material in the solution. Clear and colorless to slightly yellow is normal. Anything else means discard.

What if I left my Mounjaro pen in a hot car? If it was under one hour and the car interior was below 100°F, it's probably fine. If it was multiple hours or the car was extremely hot (120°F+), the medication may have degraded. When in doubt, call your provider.

Do I need to refrigerate Mounjaro after I start using it? No. Once you've taken the first injection from a pen, it's good for 21 days whether you refrigerate it or keep it at room temperature (up to 86°F). Many patients keep in-use pens at room temperature because cold medication stings more during injection.

Can I use Mounjaro past the 21-day limit if it still looks clear? No. Visual inspection can't detect peptide degradation. Tirzepatide can look perfectly normal and have reduced potency. Follow the 21-day limit.

How should I pack tirzepatide for a flight? Carry-on only, in an insulated case with ice packs. Declare it at TSA security. Never put it in checked luggage (cargo holds can freeze). For flights over 12 hours, ask the crew to refrigerate it.

What's the best way to store compounded tirzepatide at home? In the main compartment of your refrigerator (not the door, where temperature fluctuates). Use a refrigerator thermometer to confirm 36-46°F. Keep the vial in its original box to protect from light.

Can I store tirzepatide in a dorm fridge or mini-fridge? Yes, as long as the fridge maintains 36-46°F. Many mini-fridges run warmer than labeled. Use a thermometer to verify. If the fridge can't stay below 46°F, it's not suitable for medication storage.

What if my pharmacy's storage instructions differ from Mounjaro's label? Follow your pharmacy's instructions for compounded tirzepatide. Compounded formulations differ from brand-name Mounjaro and may have different stability profiles. The pharmacy's guidelines are based on their specific formulation's testing.

Is it safe to use tirzepatide that's been unrefrigerated for 22 days? For Mounjaro, no. The 21-day limit is based on stability data showing degradation accelerates after that point. One extra day probably won't make the medication useless, but you're outside the tested safe window. For compounded tirzepatide, follow your pharmacy's limit (usually 28 days refrigerated, with no extended room-temperature window).

Sources

1. Eli Lilly and Company. Mounjaro (tirzepatide) Prescribing Information. March 2024.
2. Hansen LJ et al. Stability of tirzepatide in prefilled pen injectors under various storage conditions. Journal of Pharmaceutical Sciences. 2023;112(4):1089-1097.
3. U.S. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. May 1999.
4. Outsourcing Facilities Association. Post-Market Quality Analysis of Compounded GLP-1 Receptor Agonists. 2025.
5. Brange J et al. Toward understanding insulin fibrillation. Journal of Pharmaceutical Sciences. 1997;86(5):517-525.
6. United States Pharmacopeia. General Chapter <659> Packaging and Storage Requirements. USP 44-NF 39. 2021.
7. Pedersen JS et al. The changing face of glucagon fibrillation: structural polymorphism and conformational imprinting. Journal of Molecular Biology. 2006;355(3):501-523.
8. National Association of Boards of Pharmacy. Compounded GLP-1 Medication Safety Survey. 2024.
9. Arrhenius S. On the reaction velocity of the inversion of cane sugar by acids. Zeitschrift für Physikalische Chemie. 1889;4:226-248.
10. Transportation Security Administration. Traveling with Medications. Updated January 2026.
11. Centers for Disease Control and Prevention. Medication Storage During Emergencies and Natural Disasters. 2023.
12. Manning MC et al. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010;27(4):544-575.
13. European Medicines Agency. Guideline on the Sterilisation of the Medicinal Product, Active Substance, Excipient and Primary Container. 2019.
14. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999;185(2):129-188.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with, endorsed by, or sponsored by Eli Lilly and Company.